abstract |
The present invention relates to a peptide composition having an anti-inflammatory effect, and is a peptide composition represented by the following formula (1) [Chemical Formula 1] Wherein R 1, R 4 and R 5 are hydrogen, R 2 and R 3 are hydroxy, K is Lys, G is Gly, T is Thr, E is Glu, and C Cys. Thus, it is possible to provide a peptide composition having an anti-inflammatory effect that inhibits the activity of PGE2 and AP-1 without increasing the in vivo delivery efficiency and inhibiting immune macrophages. |